Coralville, IA, United States of America

Collin Heer


 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Collin Heer

Introduction

Collin Heer is an accomplished inventor based in Coralville, IA (US). He has made significant contributions to the field of cancer therapy, holding two patents that focus on innovative treatment methods. His work aims to improve the efficacy of cancer treatments through novel combinations of compounds.

Latest Patents

Collin Heer's latest patents include a groundbreaking method of treating cancer using a combination of a pentaaza macrocyclic ring complex and ascorbate compounds. This method involves administering an active agent selected from ascorbic acid, its derivatives, or pharmaceutically acceptable salts, alongside the pentaaza macrocyclic ring complex. This innovative approach has the potential to enhance cancer treatment outcomes significantly.

Career Highlights

Throughout his career, Collin has demonstrated a commitment to advancing medical science. His work at Galera Labs, LLC has positioned him at the forefront of cancer research and therapy development. His innovative ideas and dedication to improving patient care have made him a notable figure in the field.

Collaborations

Collin has collaborated with esteemed colleagues, including Robert A Beardsley and Dennis Patrick Riley. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of cutting-edge treatments.

Conclusion

Collin Heer is a visionary inventor whose work in cancer therapy is paving the way for more effective treatment options. His patents reflect a deep understanding of the complexities of cancer treatment and a commitment to improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…